Literature DB >> 22675097

Tubercular serpiginous-like choroiditis.

Marta Esteves Guedes1, José Nuno Galveia, Ana Catarina Almeida, João Marques Costa.   

Abstract

Choroidal tuberculosis (TB) infection may present itself as a diffuse choroiditis that resembles serpiginous choroiditis, usually treated with immunossupressants. Recent studies have demonstrated that patients with serpiginous-like choroiditis and evidence of systemic or latent TB are best treated with antituberculosis treatment (ATT) in addition to the corticosteroid therapy. The authors present a case of a 58-year-old man with decreased vision in his left eye. His best-corrected visual acuity was 20/20 right eye and 20/200 left eye. Funduscopic examination revealed a diffuse choroiditis. Mantoux skin test showed an area of induration measuring 30×35 mm and the patient started ATT with complete resolution of retinal lesions after 2 weeks of treatment. His final visual acuity was 20/25 in the left eye with no recurrences over a follow-up of 6 months. The use of ATT in these patients is likely to reduce active inflammation and eliminate future recurrences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22675097      PMCID: PMC3207773          DOI: 10.1136/bcr.08.2011.4654

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Tuberculous uveitis: distribution of Mycobacterium tuberculosis in the retinal pigment epithelium.

Authors:  Narsing A Rao; Sindhu Saraswathy; Ronald E Smith
Journal:  Arch Ophthalmol       Date:  2006-12

2.  Tuberculous choroiditis diagnosed by chorioretinal endobiopsy.

Authors:  M J Barondes; W E Sponsel; T S Stevens; R D Plotnik
Journal:  Am J Ophthalmol       Date:  1991-10-15       Impact factor: 5.258

3.  Polymerase chain reaction for the detection of Mycobacterium tuberculosis in ocular tuberculosis.

Authors:  S Kotake; K Kimura; K Yoshikawa; Y Sasamoto; A Matsuda; T Nishikawa; N Fujii; H Matsuda
Journal:  Am J Ophthalmol       Date:  1994-06-15       Impact factor: 5.258

Review 4.  Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals.

Authors:  S Alvarez; W R McCabe
Journal:  Medicine (Baltimore)       Date:  1984-01       Impact factor: 1.889

5.  Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan.

Authors:  Yoshihiro Morimura; Annabelle A Okada; Sumie Kawahara; Yuko Miyamoto; Shin Kawai; Akito Hirakata; Tetsuo Hida
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

6.  Intraocular tuberculosis.

Authors:  P H Rosen; D J Spalton; E M Graham
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

7.  Presumed tubercular serpiginouslike choroiditis: clinical presentations and management.

Authors:  Vishali Gupta; Amod Gupta; Sunil Arora; Pradeep Bambery; Mangat Ram Dogra; Anita Agarwal
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

Review 8.  Tuberculosis.

Authors:  Khalid F Tabbara
Journal:  Curr Opin Ophthalmol       Date:  2007-11       Impact factor: 3.761

9.  Clinical characteristics of serpiginous choroidopathy in North India.

Authors:  Vishali Gupta; Anita Agarwal; Amod Gupta; P Bambery; Subina Narang
Journal:  Am J Ophthalmol       Date:  2002-07       Impact factor: 5.258

10.  The clinical course of serpiginous choroidopathy.

Authors:  H Weiss; W H Annesley; J A Shields; T Tomer; K Christopherson
Journal:  Am J Ophthalmol       Date:  1979-02       Impact factor: 5.258

View more
  2 in total

1.  Successful treatment of tubercular multifocal serpiginous-like choroiditis without use of anti-inflammatory drugs: A case report with multimodal imaging.

Authors:  Mohammad Zarei; Navid Mohsenzadeh; Ramak Roohipoor; Hamid Riazi-Esfahani
Journal:  J Curr Ophthalmol       Date:  2018-09-01

Review 2.  [Serpiginous-Like Choroiditis: literature Review]

Authors:  Cesar Arrieta-Bechara; Belén Haro-Álvarez; Angie Carrascal-Maldonado
Journal:  Rev Fac Cien Med Univ Nac Cordoba       Date:  2022-03-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.